| Speculative "Buy" Rating On Annexon: Evaluating The Potential Of ANX005 For GBS | 08/17 09:28 | seekingalpha.com |
| Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) | 08/16 16:05 | globenewswire.com |
| Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) | 07/16 16:05 | globenewswire.com |
| Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting | 07/11 18:09 | globenewswire.com |
| Are Medical Stocks Lagging Annexon (ANNX) This Year? | 06/28 10:45 | zacks.com |
| Here's Why Annexon (ANNX) Is a Great 'Buy the Bottom' Stock Now | 06/27 10:55 | zacks.com |
| Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting | 06/25 17:00 | globenewswire.com |
| Is Annexon (ANNX) Stock Outpacing Its Medical Peers This Year? | 06/07 10:41 | zacks.com |
| Annexon Announces Pricing of $125 Million Underwritten Public Offering | 06/05 23:04 | globenewswire.com |